Glioblastoma (GBM) is the most common primary malignant brain tumor, with patients exhibiting poor survival (median survival time: 15 months). Difficulties in treating GBM include not only the inability to resect the diffusively-invading tumor cells but also therapeutic resistance. The perivascular niche within the GBM tumor microenvironment contributes significantly to tumor cell invasion, cancer stem cell maintenance, and has been shown to protect tumor cells from radiation and chemotherapy. In this study, we describe the development of an in vitro artificial perivascular niche (PVN), culturing endothelial and stromal cells along with GBM cells within a methacrylamide-functionalized gelatin hydrogel, in order to examine howthe presence of the PVN alters global genomic expression profiles. Using RNA-seq, we demonstrate that the inclusion of perivascular niche cells with GBM cells upregulates genes related to angiogenesis and remodeling, while downregulated genes are related to cell cycle and DNA damage repair.
Introduction
Glioblastoma (GBM) is the most common primary malignant brain tumor. Prognosis is grim for GBM patients, with a median survival time of approximately 15 months [1] . Unlike many solid tumors where mortality is linked to metastasis [2] , GBM tumors rarely metastasize. Instead, GBM spreads diffusively through the brain by invading along structural elements such as white matter tracts and blood vessels [3] [4] [5] [6] .Treatment is complicated by the diffuse spreading of tumor cells throughout the brain parenchyma. Poorly-defined tumor margins therefore limit the effectiveness of surgical resection, with tumor cells inevitably left behind after debulking.
Subsequent radiation and chemotherapy have limited effect on the remaining tumor cells, with GBM tumors rapidly recurring (median: 6.9mo post debulking) at a site often in close proximity (>90% within 2cm) of the original resection cavity [1, 7] . The need for improved treatment methods for GBM highlights the importance of developing tools to facilitate the understanding of mechanisms of GBM invasion, the role played by interactions between GBM cells and the heterogeneous cell and matrix environment in the surrounding parenchyma, as well as to facilitate drug development and screening.
The heterogeneity of the GBM microenvironment presents a challenge in dissecting the biophysical, biochemical, and cellular cues that drive GBM invasion. In particular, the microenvironment hosts a variety of cell types, including astrocytes, microglia, neural stem cells, pericytes, and endothelial cells, whose interactions with GBM cells have been demonstrated to contribute to heightened invasion potential [8] . Endothelial cells and stromal cells such as pericytes and fibroblast are components of the perivascular niche, in which interactions between blood vessels and GBM cells have been implicated in a variety of roles that promote GBM progression [8, 9] . Tumor cells have been shown to associate closely with blood vessels through co-option as they invade into the surrounding brain parenchyma [4, 10, 11] . Co-opted vessels ultimately undergo regression, triggering hypoxic signaling (HIF-1) in the surrounding tumor tissue [12] [13] [14] [15] [16] . Subsequent secretion of pro-angiogenic factors such as VEGF induces sprouting angiogenesis at the tumor periphery [12, 15] . GBM cells migrates towards these newly-formed blood vessels, thereby pushing the invasive front of the tumor further into the brain parenchyma. Additionally, the perivascular niche potentially contributes to maintenance of cancer stem cells, a highly-resistant subpopulation of cells implicated in tumor recurrence [9, 17, 18] . Crosstalk between endothelial and cancer stem cells may be governed by Notch signaling, which would promote angiogenic activity and stem cell maintenance [8, 9, 17] . The alreadydemonstrated roles of perivascular cells in promoting GBM invasion warrants further investigation into mechanisms governing endothelial-GBM cell interactions, inhibitors of this cross-talk, and how the interactions between these cell types mediates therapeutic response.
Investigating the interactions between multiple cell types traditionally utilizes conditioned medium in 2D cell culture or migration assays (e.g. Transwell ®), as well as immunofluorescent or immunohistochemical staining and imaging [4, 19, 20] . However, the inability of 2D culture to accurately predict therapeutic response and the complexity of animal models has paved the way for the development of 3D in vitro models, which utilize materials such as hydrogels to recapitulate elements of the tumor microenvironment [21] [22] [23] . To date, 3D in vitro models for GBM primarily incorporate only tumor cells, despite the demonstrated contributions of additional cell types to in vivo GBM behavior [6, [24] [25] [26] [27] [28] [29] [30] . A few studies have examined the interactions between GBM cells, perivascular niche cells, and macrophages within 3D in vitro platforms, but these models feature spatial segregation between the different cell types that is not reminiscent of the in vivo microenvironment [20, [31] [32] [33] [34] . Mixed cultures of tumor cells, endothelial cells, and stromal cells have been achieved within biomaterials for breast, lung, and prostate cancers, and these models have been used to investigate how non-tumor cells impact tumor proliferation, phenotype, and therapeutic response [35] [36] [37] [38] [39] . Our lab has recently described a tri-culture biomaterial platform for the purpose of modeling the perivascular niche of GBM [40] . We demonstrated the formation of endothelial cell networks in gelatin hydrogels by co-culturing endothelial cells and fibroblasts. Tri-culturing GBM cells alongside these perivascular cells resulted initially in close association between GBM cells and developing endothelial cell networks, followed by dissolution of these networks in a manner similar to vessel co-option and regression in vivo. Since hyaluronic acid is an important component of the GBM tumor microenvironment [41] , we additionally investigated the effect of matrix-bound hyaluronic acid on endothelial network formation and regression. In this study, we investigated how the presence of a perivascular niche established by endothelial cells and fibroblasts alongside GBM cells alters the global genomic profile of our in vitro model within a three-dimensional gelatin hydrogel. We use RNA sequencing (RNA-seq) to determine differentially-expressed genes resulting from tri-culturing perivascular cells with GBM cells, comparing results to cultures of GBM cells alone and perivascular cells cultured in the absence of tumor cells. Additionally, we traced the expression of select genes commonly implicated in GBM malignancy (e.g. VEGF, HIF1α, MMP9, TNC, EGFR) as a function of time and the presence of hydrogel immobilized hyaluronic acid content. We further investigated how the presence of perivascular niche established by culture with endothelial and stromal cells acts as a protectant against GBM cell response to temozolomide (TMZ), the frontline alkylating agent used clinically to treat GBM.
Materials and Methods

Cell Culture
Human umbilical vein endothelial cells (HUVECs) and normal human lung fibroblasts (NHLF) were purchased from Lonza (Walkersville, MD) and used before passage 6 and passage 8 respectively. HUVECs were cultured in EGM-2 media containing 2% FBS and supplements such as hEGF, hydrocortisone, VEGF, hFGF-B, R 3 -IGF-1, ascorbic acid, heparin, and gentamicin/amphotericin-B (Lonza, Walkersville, MD) [42] . NHLFs were cultured in FGM-2 media containing 2% FBS and supplements such as hFGF-B, insulin, and gentamicin/amphotericin-B (Lonza, Walkersville, MD) [2] . U87-MG cells, a gift from Professor Nathan D. Price (ISB, Seattle), were cultured in DMEM with 10% FBS and 1% penicillin/streptomycin [28] . All cell types were cultured at 37 °C in 5% CO2.
Fabrication of cell seeded gelatin hydrogels
Two distinct hydrogel formulations were used throughout all experiments. Both hydrogel variants were based on a methacrylamide-functionalized gelatin (GelMA) macromer previously developed in our lab for culture of GBM cells [27] [28] . GelMA and HAMA were synthesized as previously described, and the degree of functionalization of GelMA was determined to be 50% by 1 H NMR [28] . GelMA alone or GelMA combined with 15% w/w HAMA (GelMA + HA) were dissolved in PBS at 65 °C to form 4 wt% polymer solutions. Lithium acylphosphinate (LAP) was added as a photoinitiator at 0.1% w/v for GelMA-only gels and 0.02% w/v for GelMA/HAMA gels. The reduced photoinitiator concentration allowed for equivalent elastic moduli (~3 kPa) between the GelMA and GelMA + HA constructs [40] . Cell seeded hydrogels (GelMA only;
GelMA+HA) were then formed in one of three configurations: GBM-only; Perivascular-only; or Tri-Culture. GBM-only cultures were formed by re-suspending 1 × 10 5 U87-MGs/mL in the GelMA or GelMA+HA polymer solution. Perivascular-only cultures were formed by resuspending 1 × 10 6 HUVECs/mL and 2 × 10 6 NHLFs/mL in the GelMA or GelMA+HA polymer solution. Tri-Cultures were formed by re-suspending 1 × 10 6 HUVECs/mL, 2 × 10 6 NHLFs/mL, and 1 × 10 5 U87-MGs/mL in the GelMA or GelMA+HA polymer solution. Cell-laden solutions were subsequently pipetted into circular Teflon molds with a diameter of 5 mm and a thickness of 1 mm, and exposed to UV light at a wavelength of 365 nm and intensity of 5.69 mW/cm 2 for 30 s as previously described to form cell-seeded hydrogel disks [40] . Hydrogels were maintained for up to 14 days in 48-well plates in EGM-2 media with daily media changes.
Flow cytometric analysis of GBM and perivascular populations
Perivascular-only cultures (endothelial and stromal cells) and Tri-Cultures (GBM, endothelial, and stromal cells) were dissociated using a protocol adapted from van Beijnum et al. [43] 
RNA Isolation and Quality Analysis
Hydrogels were collected at 0, 3, 7, and 14 days and stored at -80 °C until RNA extraction. RNA was extracted using an RNeasy Plant Mini Kit, followed by DNase digestion using a RNase-free DNase set (Qiagen, Hilden, Germany) [44] . RNA samples for RNA-seq were analyzed for quality using an Agilent 2100 bioanalyzer (Agilent, Santa Clara, CA). Samples with a minimum RIN of 7 were used for RNA-seq [45] . Quality testing of RNA was performed by the Roy J.
Carver Biotechnology Center at the University of Illinois Urbana-Champaign.
RNA-seq analysis of Tri-Culture hydrogels
RNA-seq was performed on RNA samples from the Tri-Culture hydrogels (GBM, endothelial, and stromal cells), as well as RNA samples comprised of a mixture of RNA from the Perivascular-only and GBM-only culture conditions (Mixed). The comparison between Tri-Culture and Mixed samples was inspired by the methodology described by Lilly et al. [46] . Mixed samples were constructed such that the CD90+ fraction of the Tri-Culture and Mixed samples were equal. Libraries for RNA sequencing were prepared using the TruSeq Stranded mRNAseq Sample Prep Kit (Illumina, San Diego, CA), which fragments the mRNA, reverse transcribes it to cDNA, and adds sequence adaptors [47] . Libraries were subsequently quantitated with qPCR and sequenced by using the HiSeq 4000 sequencing kit version one in conjunction with a HiSeq 4000 (Illumina, San Diego, CA). 100 nt single-end reads were generated in 101 cycles to yield 55 -70 million reads per sample. Library preparation and sequencing were performed by the Roy J. Carver Biotechnology Center at the University of Illinois Urbana-Champaign.
Library quality was checked using FastQC, and Trimmomatic [48] was used to remove lowquality reads. Trimmed libraries were subsequently aligned to the human genome (GRCh38.p10) using STAR [49] , and featureCounts [50] was used to categorize the aligned reads to genes and other genomic features. 45393 genes were identified from the reads. Differential gene expression analysis was performed in R using limma and edgeR packages [51] [52]. Quality control was performed to filter out genes with few counts using a threshold of 0.5 counts per million, with 14269 genes remaining after applying the threshold. This accounted for >99% of the counts and 31% of the identified genes. TMM normalization was performed before determining differentially expressed genes. Functional annotation was performed, followed by gene ontology (GO) and KEGG pathway analyses using GOstats [53] .
Real-time PCR
RNA was reverse transcribed to cDNA using reagents from the QuantiTect Reverse Transcription Kit (Qiagen, Hilden, Germany) and a Bio-Rad MyCycler thermal cycler (Bio-Rad, Hercules, CA). Real-time PCR was performed in an Applied Biosystems QuantStudio 7 Flex PCR System (Thermo Fisher Scientific, Waltham, MA) using Taqman Fast Advanced Master Mix and Taqman Gene Expression Assays (Thermo Fisher Scientific, Waltham, MA) ( Table 1) .
RPS20 was used as the housekeeping gene [54] . Fold change was calculated using the ΔΔCT method and normalized to expression at Day 0 in hydrogels without HAMA [55] .
Analysis of GBM response to Temozolomide (TMZ)
Tri-culture and GBM-only hydrogels were developed with and without HAMA and cultured for 7 days in EGM-2 media with daily media change. After 7 days of culture, TMZ (Sigma Aldrich, St.
Louis, MO) was added at 0, 100, 250, and 500 µM to all hydrogels for 48 hours. To assess cellular response to TMZ, metabolic activity was assessed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Thermo Fisher Scientific, Waltham, MA) 48 hours after treatment [56] . Hydrogels were incubated in 200 µL EGM-2 media and 20 µL MTT solution for 4 hours at 37 °C. The resultant formazan was solubilized into 300 µL DMSO (Sigma Aldrich, St. Louis, MO) overnight. Absorbance was read at 540 nm using a BioTek Synergy HT microplate reader (BioTek, Winooski, VT). Metabolic activity for treated samples was normalized to the untreated control. Additionally, growth rate inhibition (GR), as described in Hafner et al. [57] , was measured in hydrogels at concentrations of 0, 25, 100, 250, and 500 µM TMZ after 7 days of culture. Relative cell count was assessed after 48 hours after treatment with the CellTiter-Glo Luminescent Cell Viability assay (Promega, Madison, WI) using a protocol derived from Lin et al. [58] . Briefly, hydrogels were incubated for one hour at room temperature in 150 µL EGM-2 media mixed with 150 µL CellTiter reagent. Luminescence was read using a BioTek Synergy HT microplate reader. Initial cell counts were obtained by running the assay on untreated hydrogels on the day of treatment. GR metrics were calculated as described by
Hafner et al. [57] , and the GR50 was calculated using the Online GR Calculator (www.grcalculator.org/grcalculator). DMSO at the highest relative concentration was used as the untreated control (0 µM).
Statistics
Statistical analysis for real-time PCR and drug treatment experiments was performed using oneway ANOVA followed by Tukey post hoc in OriginPro (OriginLab, Northampton, MA). Differential gene expression, gene ontology, and KEGG pathway analyses were performed in R as previously described. All experiments used n = 3 hydrogels per group. Significance was set at p < 0.05 for all analyses except for differential gene expression, in which an FDR adjusted p-value < 0.05 was used. Data are presented as mean ± SD.
Results
Presence of perivascular niche cells alters genomic profile of glioblastoma within gelatin hydrogels
We used RNA-seq to analyze the genomic profile of Tri-Culture GelMA-only hydrogels in contrast with Perivascular-only and GBM-only GelMA-only hydrogels. RNA from the Tri-Culture Figure 1 . Schematic of workflow for preparing RNA samples for RNA-seq. RNA was extracted from GBM-only, Perivascular-only, and Tri-Culture hydrogels. Flow cytometry was performed on cells from additional Perivascular-only and Tri-Culture hydrogels to obtain the fraction of CD90 + cells in each culture system. GBM-only and Perivascular-only RNA were subsequently combined to form a Mixed sample such that the CD90 + fraction of the Mixed sample was equal to that in the Tri-Culture sample. Mixed and Tri-Culture RNA were subsequently sequenced. hydrogels (Tri-Culture) was compared to RNA samples (Mixed) constructed from combining RNA from separate Perivascular-only and GBM-only hydrogels (Figure 1) , such that the CD90+ fraction (NHLF sub-population) of the mixed samples would match that in the Tri-Culture samples ( Table 2) Table 1 ). Downregulated genes also included those related to hyaluronic acid production and binding (e.g. HAS1, HMMR), proliferation (e.g. MKI67), cell cycle (e.g. CDKN2B, RBL1, BUB1, BUB1B), and DNA damage repair (e.g. MSH2, MSH6, MLH1) (Supplementary Table 2 ).
We subsequently used Gene Ontology (GO) analysis to identify over-represented terms amongst upregulated and downregulated genes. Specifically, over-represented GO terms amongst upregulated genes included those related to response to stimulus, signaling, development, cell motility, secretion, regulation of cell death, adhesion, neurogenesis, vascular development and angiogenesis, hypoxia, ECM organization, and fibroblast activation (Supplementary Table 3 ). Within downregulated genes, terms related to RNA processing and stability, DNA damage detection and response, response to oxidative stress, double-strand break repair, and postreplication repair were over-represented ( Supplementary Table 4 ).
Additionally, terms related to metabolism, biosynthesis, cell cycle and proliferation regulation, base excision repair, and regulation of gene expression, transcription, and silencing were overrepresented amongst both upregulated and downregulated genes.
KEGG pathway analysis revealed various signaling cascades, including Notch, MAPK, and HIF-1 were over-represented amongst upregulated genes (Figure 3a) . Additional over-represented Table 5 ). Notably, over-represented amongst downregulated genes were terms related to metabolism, biosynthesis and degradation, cell cycle, DNA replication, and various DNA damage repair mechanisms (Figure 3b, Supplementary Table 6 ).
Malignancy-related genes vary temporally in tri-culture hydrogels
We subsequently used real-time PCR to investigate the kinetics of gene expression in Tri-Culture hydrogels over a period of 14 days (Figures 4 -6) . We examined a panel of genes related to angiogenesis (i.e. VEGF, VEGFR1, ANG1, ANG2, TIE2), hyaluronic acid synthesis and signaling (i.e. RHAMM, HAS1, HAS2), re-modeling (i.e. MMP9), PDBF signaling (i.e. PDGFB, PDGFRA, PDBFRB), hypoxia (i.e. HIF1α), proliferation (i.e. KI67), stromal cross-talk (i.e. FAP), as well as TNC and EGFR, which have been previously implicated in GBM progression in literature [54] [61] . These genes were chosen from those that were identified as significantly upregulated or downregulated in the RNA-seq analysis, or from those implicated in (Figure 4d) . FAP expression, which relates to stromal activation, was significantly downregulated by Day 14 (Figure 6a) . HIF1α expression trended downwards with time, while TNC expression trended upwards. We additionally investigated the kinetics of Tri-Culture gene expression patterns in HAfunctionalized GelMA hydrogels. For genes related to angiogenesis, trends were similar to those observed in the absence of HAMA (Figure 5a) . However, VEGR1 and ANG2 were downregulated with the presence of HAMA at Day 3, while TIE2 was upregulated at Day 7 compared to cultures without HAMA. In contrast to cultures without HAMA, in which both RHAMM and HAS2 trended downwards with time, expression in cultures with HAMA trended towards a peak at Day 7 (Figure 5b) . Hyaluronic acid synthase genes HAS1 and HAS2 were significantly upregulated at Day 7 with the presence of HAMA while the gelatinase MMP9 was significantly upregulated with time, with further increased expression at Day 7 in the presence of matrix-bound HA (Figure 5c ). Additionally, PDGFB and PDGFRA were upregulated at Day 7 in hydrogels with covalently-bound HA (Figure 5d) . In contrast to GelMA-only cultures, PDGFRB trended towards a peak at Day 7 instead of Day 3 (Figure 5e ). Trends in FAP and TNC expression were not altered by HAMA (Figure 6b) . While HIF1α remained relatively constant with time, KI67 and EGFR expression both appeared to peak at Day 7.
Presence of covalently-bound hyaluronic acid within the hydrogels alters gene expression profiles
Tri-culture and GBM-only hydrogels differentially respond to TMZ
The comparison of Tri-culture hydrogels to Perivascular-only and GBM-only hydrogels using RNA-seq revealed significant upregulation of MGMT and significant downregulation of genes associated with DNA mismatch repair, which has been implicated in resistance to TMZ, the standard chemotherapy for GBM [65] . As such, we hypothesized that Tri-culture hydrogels would demonstrate increased resistance to TMZ compared to GBM-only hydrogels. GBM cells were allowed to stabilize in GelMA and GelMA+HA hydrogels for seven days before treatment to allow the establishment of a perivascular niche-like environment within the Tri-Culture hydrogels. We analyzed response to TMZ 48 hours after treatment by assessing changes in metabolic activity and growth rate inhibition. In response to TMZ treatment the metabolic activity of GBM cells in GelMA hydrogels decreased significantly (250 µM, 500 µM TMZ) compared to untreated controls for GBM-only cultures (Figure 7a) . The presence of matrix-immobilized HA did not significantly alter the reduction in metabolic activity in GBM-only cultures. Interesting, Tri-Culture hydrogels that contained a perivascular culture did not exhibit significant decreases in metabolic activity until application of 500 µM TMZ, and there only for HA-modified GelMA hydrogels. Metabolic activity trended downwards for Tri-Culture hydrogels in GelMA only hydrogels but was never significantly diminished over the range of tested TMZ concentrations. We additionally used a cell-viability assay to measure growth rate inhibition in GBM-only and Tri-Culture hydrogels in response to TMZ treatment (Figure 7b ). In corroboration with trends observed in metabolic activity, we did not observe growth rate inhibition in Tri-Culture hydrogels across the concentrations tested. In contrast, growth rate (GR) values decreased with increasing TMZ concentrations in GBM-only hydrogels. Using the Online GR Calculator, we estimated GR50 = 232 µM for GBM-only GelMA-only hydrogels and GR50 = 160 µM for GBMonly GelMA+HAMA hydrogels. With 500 µM TMZ treatment, we observed significantly reduced GR values for GBM-only cultures versus Tri-Culture environments containing a perivascular niche (Figure 7b ).
Discussion
GBM progression is believed to be linked to the interactions of cancer cells with endothelial cells
and associated stromal cells within the perivascular niche. Previous efforts have shown GBM invasion into healthy brain parenchyma proceeds along blood vessels, with vessel co-option followed by subsequent regression and angiogenic sprouting at the tumor periphery further expands the tumor margins [11, 12, 15] . The perivascular niche has also been implicated in the maintenance of cancer stem cells, potentially through crosstalk between cancer stem cells and endothelial cells via Notch signaling, and may potentially contribute to GBM resistance to therapy [17, 18, 66, 67] . Previously, predominantly 2D culture or Transwell-based migration assays, as well as in vivo animal models, have been traditionally used to study interactions between GBM and endothelial cells [4, 19] . However, 2D and Transwell models may be limited by the lack of a 3D matrix architecture or limited direct cell-cell contact. Animal models are physiologically relevant, but difficulties exist in extracting sufficient quantities of analyzing cell subpopulations [68] . Further, the timescale for in vivo studies can be disadvantageous for developing real-time and personalized therapeutic regimens. The potential for 3D in vitro models of GBM to recapitulate physiologically-relevant phenotype in a timely manner has already been demonstrated through a variety of biomaterials using PEG, collagen, hyaluronic acid, and gelatin chemistries [24, 25, 28] . However, few models have included additional cell types in co-culture with GBM cells [20, 33] , suggesting that a 3D in vitro model of the GBM perivascular niche may be particularly advantageous given its suggested role in promoting invasion and therapeutic resistance.
We have previously demonstrated that endothelial cell networks can be sustained and tuned within gelatin hydrogels using a co-culture and endothelial cells and fibroblasts [40] . We also observed that including U87-MG GBM cells in the culture system leads to close association between GBM cells and the developing endothelial cell networks, followed by dissolution of these networks in a manner reminiscent of co-option [69] . In this study, we were interested in defining the degree to which the addition of a perivascular niche within the hydrogel culture alters the genomic profile of the in vitro model compared to hydrogels containing only GBM cells. We additionally quantified the kinetics of genomic changes that accompanied the development and dissolution of the endothelial cell networks over 14 days of culture in vitro.
And based on the mechanism of action of the alkylating agent TMZ used currently as a frontline GBM therapy in the clinic as well as result of the global RNA-seq analysis, we examined whether the in vitro perivascular niche provided a protective environment against TMZ therapy.
We utilized RNA-seq to determine if the inclusion of perivascular niche cells within the hydrogel model further promoted the recapitulation of characteristics of GBM phenotype compared to culturing GBM cells or perivascular niche cells alone after 7 days of culture. Upregulation of angiogenesis-related genes correlated to in vitro observations that GBM cells promote endothelial cell migration and capillary formation, and was also consistent with previous findings using in vivo models and patient samples [20, 33, 63, [70] [71] [72] . Differential gene expression analysis also demonstrated upregulation of several genes previously linked to GBM malignancy, such as the matrix metalloproteinases, PDGFB and PDGF receptors, TNC, FN1, and EGFR, consistent with previous findings using conventional cell culture and analysis of patient and xenograft-derived tumor specimens [54, 61, [73] [74] [75] . KEGG pathway analysis additionally confirmed the over-representation of various signaling cascades commonly dysregulated in GBM amongst upregulated genes, such as Notch, NF-κβ, Jak-STAT, HIF-1, MAPK, Ras, and PI3K-Akt [9] [76] [77] [78] , all in the case of GBM cells exposed to a perivascular environment.
Notch signaling in particular has been previously associated with the perivascular niche and implicated in cancer stem cell maintenance and angiogenesis associated with poor patient outlook [9, 17] . The results of this analysis suggest that crosstalk between GBM and non-GBM perivascular niche associated cell types within the microenvironment contributes to the overall tumor phenotype.
KEGG pathway and GO analysis revealed that while upregulated genes in the presence of a perivascular environment were commonly associated with cell migration, downregulated genes were linked to cell cycle and proliferation. These results correlate with the "go or grow" hypothesis, which suggests that cells will either migrate or proliferate at a given point in time [79] . The relevance of the "go or grow" hypothesis in GBM has been demonstrated by Mariani et al., who used microarray analysis to show that cell cycle, proliferation, and apoptotic genes were downregulated in migrating GBM cells [80] . Additionally, time-lapse imaging performed by Farin et al. demonstrated that while GBM cells invade along blood vessels, these cells would stop migrating in order to proliferate before resuming movement [11] . It has also been shown that endothelial cells within the GBM microenvironment are more migratory and less proliferative than endothelial cells from normal brain tissue, which would further correlate to the results observed in this study [81] . Interestingly, downregulated genes in the Tri-Culture (GBM cells in the presence of a perivascular environment) also included those previously shown to be upregulated in GBM, such as ADGRG1 and CD74 [59] . Discrepancies between the results presented here and those from prior literature may be explained by the fact that we compared RNA from the Tri-Culture model to RNA from a mixture of tumor and non-tumor cells, as opposed to non-malignant cells or tissue. This comparison was made to contrast between 3D in vitro models containing GBM cells alone and GBM cells in culture with perivascular niche cells.
Further validation of our Tri-Culture model may be achieved by performing differential gene expression analysis against a model of non-malignant brain tissue.
Vessel co-option and regression has been observed to precede sprouting angiogenesis at the tumor margins in GBM [12] . Holash et al. described the expression of ANG2 by co-opted vessels within an in vivo model, as well as delayed expression of VEGF after regression occurs [12] . ANG2 is also expressed by vessels formed as a result of angiogenesis that occurs after regression. Within our tri-culture model, we observed behavior reminiscent of co-option and regression over the course of 14 days. ANG2 expression was highest at Day 3, when close association was already observed between developing endothelial network structures and U87-MG cells. Since an angiogenic response to regression was not observed within the culture period, ANG2 expression was not expected at Day 14. On the other hand, maximal VEGF expression as observed at Day 14, most likely as a response by the tumor cells to the regressing endothelial network regression. Decreasing expression of VEGFR1 and TIE2, which are both found on endothelial cells, additionally accompanied regression and the associated endothelial cell apoptosis. We also observed decreasing expression of FAP and PDGFRB, which are both associated with stromal and endothelial cells [63] . This trend may also be linked expression did not change with tumor progression, we observed a decline in ANG1 expression over the culture period [12, 82] . While this could be explained by apoptosis of the tumor cells, investigation into cell type-specific genomic profile changes will help us resolve the role of ANG1 within our model. In addition to profiling of genes implicated in vascular regression and angiogenesis, we analyzed the kinetics of genes commonly implicated in GBM progression via RT-PCR. We observed significant upregulation of MMP9, which Raithatha et al. showed to be expressed by both tumor cells and vessels in vivo [73] . TNC expression also increased during the culture period, consistent with observations of TNC upregulation in samples from GBM patients with poor prognosis [54] . These trends, as well as constant expression of EGFR and HIF1, provide evidence that the tri-culture model recapitulates elements of the in vivo phenotype of GBM.
Hyaluronic acid (HA) is a major component of the GBM microenvironment, and interactions with between tumor cells and HA through CD44 and other HA receptors impacts GBM phenotype [6, 28, 30, 41, 83] . While gene expression trends for GBM cells in the presence of a perivascular niche were largely conserved in GelMA hydrogels with the presence or absence of matriximmobilized HA, we observed increased expression of HAS1 and HAS2 at Day 7 in HAdecorated hydrogels, consistent with previous findings in our lab regarding GBM invasion mechanisms that also observed that HAS1 and HAS2 expression increased in the presence of matrix-bound HAMA [30] . We also observed PDGF signaling was increased at Day 7 in the presence of HAMA, further suggesting that the composition of the microenvironment plays a role in determining GBM behavior.
The ability for 3D in vitro models of GBM to accurately recapitulate in vivo phenotype presents opportunities for such platforms to be used to investigate drug response in an efficient manner and potentially facilitate drug discovery. The current standard chemotherapy for GBM is temozolomide (TMZ), and MGMT expression as well as the DNA mismatch repair (MMR) pathway are two mechanisms implicated in TMZ resistance [65] . Based on the upregulation of MGMT and the downregulation of MMR genes in the Tri-Culture as observed via RNA-seq, we hypothesized that the Tri-Culture hydrogels would be more resistant to TMZ treatment compared to GBM-only hydrogels. We confirmed heightened resistance to TMZ in the tri-culture compared to the GBM-only model using metabolic and cell viability assays. Metabolic activity in the Tri-Cultures was essentially unchanged compared to the untreated control across all tested drug concentrations, while metabolic activity declined in the GBM-only model at the highest concentrations of TMZ. Additionally, growth rate inhibition was only observed in GBM-only hydrogels, with significantly decreased growth metrics in the GBM-only hydrogels versus the Tri-Culture environment at the highest concentration of TMZ. The differential response to TMZ observed between the two models corroborates with the RNA-seq results. MGMT has been implicated in repairing the O 6 -methylguanine lesion caused by TMZ action [84] , and MGMT silencing through promoter methylation is seen in a fraction of GBM patients, who respond more favorably to TMZ treatment compared to patients with functioning MGMT [85] . Additionally, functional MMR mechanisms lead to apoptosis after exposure to TMZ, and thus downregulation would lead to resistance [65] . The perivascular niche has been associated with therapeutic resistance, partially due to its ability to maintain a resistant cancer stem cell population [18] , however in this study the GBM cell line we employed does not contain a measurable GBM stem cell population (not shown). Studies have suggested that endothelial cells are resistant to TMZ, which would additionally contribute to resistance [86, 87] . Taken together, these results demonstrate that the tri-culture model recapitulates heightened therapeutic resistance associated with the perivascular niche, and represents a promising opportunity for future studies that deduce signaling pathways contributing to resistance and propose potential inhibitors to improve therapeutic response.
Overall, we demonstrate that the inclusion of perivascular niche cells in a 3D in vitro model of GBM allows for further recapitulation of elements of in vivo phenotype within the model, including resistance to TMZ. We acknowledge that use of this platform is limited by our current approaches in analyzing the global genomic and proteomic profiles of the culture system as a whole. While these results have been informative in determining the overall similarities between this in vitro model and native GBM, future work will interrogate genomic and secretome profiles of endothelial and tumor cell subpopulations individually in order to understand specific cell-cell interactions that occur within the perivascular niche to drive GBM malignancy. Techniques such as single-cell RNA-seq and heavy isotope labeling have been used in recent literature to study cell-cell interactions in GBM and other tumor types, and can be used with this tri-culture model [88] [89] [90] . Additionally, in order to investigate angiogenic events after vessel regression, we must add spatial resolution to the platform such that tumor cells are invading into an existing endothelial cell network, as opposed to the network developing in the presence of tumor cells.
Our lab has developed methods to create spatially-graded hydrogels for the culture of patientderived GBM biospecimens and to examine therapeutic resistance to EGFR tyrosine kinase inhibitors [29, 91] , and could be adapted to generate spatially-graded perivascular models. The transition from GBM cell lines to patient-derived cells provides an opportunity to use this approach to study the behavior of cancer stem cells and their interactions with artificially created perivascular niches within a hydrogel environment. We plan to culture patient-derived xenograft specimens that contain stem cell populations alongside brain-specific perivascular niche cells in order to further understand interactions that drive cancer stem cell maintenance and therapeutic resistance. Overall, this platform will be useful for studies examining that mechanisms that govern initial associations between GBM and endothelial cells that eventually lead to invasion, as well as those that contribute to therapeutic resistance within the perivascular niche.
Conclusions
The perivascular niche in GBM has been implicated in contributing to tumor invasion and therapeutic resistance. Incorporating elements of the perivascular niche into 3D in vitro platforms is therefore instrumental in improving the usefulness of this culture system for understanding tumor biology and accurately predicting therapeutic outcome. We report that the inclusion of endothelial cells and fibroblasts in co-culture with U87-MG cells within GelMA hydrogels produces a gene expression profile that allows for further recapitulation of elements of in vivo GBM phenotype. Upregulation of genes related to motility and signaling alongside downregulation of genes related to cell cycle point towards a model that supports the "go or grow" phenotype. Temporal changes in gene expression additionally supported observations of endothelial network co-option and regression during the culture period. Finally, we observed enhanced resistance to the alkylating agent TMZ for GBM cells cultured in the presence of a perivascular niche in GelMA hydrogels as opposed to culture of GBM cells alone. Together, these results suggest that this platform recapitulates characteristics of native GBM behavior within the perivascular niche, and can be used to further interrogate interactions between GBM and vascular structures that contribute to tumor progression. 
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